Antifungal Nanomaterials: Current Progress and Future Directions

Author:

Xu Jia-Le1,Luo Yu-Xuan1,Yuan Sheng-Hao1,Li Li-Wen1,Liu Ning-Ning1

Affiliation:

1. Center for Single-Cell Omics, School of Public Health, Shanghai Jiao Tong University School of Medicine, 200025 Shanghai, China

Abstract

ABSTRACT Fungal infection poses a severe threat to human health worldwide resulting in a serious problem in clinic. Due to the limited arsenal of existing antifungal drugs, the nanomaterials were thus regarded as the candidate for developing new antifungal drugs. On the one hand, the antifungal nanomaterials are divided into inorganic nanomaterials, organic nanomaterials, and hybrid nanomaterials, among which inorganic nanoparticles include metal and semiconducting categories. On the other hand, they can also be divided into inorganic particles, organic structures, and mixed nanostructures. Currently various directions for the research and development of antifungal nanomaterials are undergoing. To improve the antifungal effect, the chemical modification of nanomaterials and combination with the available drugs are two strategies widely used. In addition, optimizing the synthetic process of nanomaterials is also a major method to broaden their antifungal application. This review focuses on the current research progress and cutting-edge technologies of antifungal nanomaterials in the field of pharmacodynamics, synthesis and combination of drugs. The nanomaterial will provide a promising and broadly effective antifungal strategy and represent a potentially repositionable candidate for the treatment of fungal infections.

Publisher

Innovative Healthcare Institute

Subject

General Medicine

Reference40 articles.

1. Li M-h, Tan Q-m. Clinical application of antifungal drugs [in Chinese]. People's Military Doctor. 2007; 1: 32– 34.

2. Zhang Y, S-m Chen, Guo S-y, Hou W-t, Jiang Y-y, An M-m. Advances in research on new antifungal drugs [in Chinese]. The Fungus Sinica. 2019; 038: 1253– 1263.

3. Campoy S, Adrio JL. Antifungals. Biochem Pharmacol. 2016; 133: 86– 96.

4. Wang Y, Huang H, Li J-f, Wen X-d, Jiang Y-y. Advances in the study of fungal drug resistance [in Chinese]. Pharmaceutical Care and Research. 2009; 3: 13– 17.

5. Pfaller MA, Pappas PG, Wingard JR. Invasive fungal pathogens: current epidemiological trends. Clin Infect Dis. 2006; 43 (suppl 1): S3– S14.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3